APA (7th ed.) Citation

Grill, J. D., Raman, R., Flournoy, C., Ernstrom, K., Pierce, A., Smith, A., . . . Sultzer, D. (2025). Disclosure of elevated amyloid status is not associated with long‐term suicidality in a preclinical AD trial. Alzheimer's & dementia, 21(2), e14623-n/a. https://doi.org/10.1002/alz.14623

Chicago Style (17th ed.) Citation

Grill, Joshua D., et al. "Disclosure of Elevated Amyloid Status Is Not Associated with Long‐term Suicidality in a Preclinical AD Trial." Alzheimer's & Dementia 21, no. 2 (2025): e14623-n/a. https://doi.org/10.1002/alz.14623.

MLA (9th ed.) Citation

Grill, Joshua D., et al. "Disclosure of Elevated Amyloid Status Is Not Associated with Long‐term Suicidality in a Preclinical AD Trial." Alzheimer's & Dementia, vol. 21, no. 2, 2025, pp. e14623-n/a, https://doi.org/10.1002/alz.14623.